Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 131, Issue 2, Pages 239-250
Publisher
Wiley
Online
2014-06-20
DOI
10.1111/jnc.12798
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
- (2014) A. Beilina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2
- (2014) Renée Vancraenenbroeck et al. Frontiers in Molecular Neuroscience
- Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle
- (2013) Evy Lobbestael et al. BIOCHEMICAL JOURNAL
- Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies
- (2013) Paul Davies et al. BIOCHEMICAL JOURNAL
- Viral vectors expressing a single microRNA-based short-hairpin RNA result in potent gene silencing in vitro and in vivo
- (2013) Luísa Osório et al. JOURNAL OF BIOTECHNOLOGY
- The CRAPome: a contaminant repository for affinity purification–mass spectrometry data
- (2013) Dattatreya Mellacheruvu et al. NATURE METHODS
- Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2
- (2012) Renée Vancraenenbroeck et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Kinases as Targets for Parkinson's Disease: From Genetics to Therapy
- (2012) Renee Vancraenenbroeck et al. CNS & Neurological Disorders-Drug Targets
- LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis
- (2012) Samer Matta et al. NEURON
- Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation
- (2012) Spencer B. Hermanson et al. PLoS One
- Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers
- (2012) Laura Civiero et al. PLoS One
- The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperones
- (2011) Jing Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning
- (2011) M. W. Dodson et al. HUMAN MOLECULAR GENETICS
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
- (2011) Owen A Ross et al. LANCET NEUROLOGY
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- On the Road to Leucine-Rich Repeat Kinase 2 Signalling: Evidence from Cellular and in vivo Studies
- (2011) V. Daniëls et al. NEUROSIGNALS
- Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
- (2011) Xianting Li et al. PLoS One
- LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
- (2011) Jean-Marc Taymans et al. PLoS One
- Leucine-rich repeat kinase LRRK1 regulates endosomal trafficking of the EGF receptor
- (2011) Hiroshi Hanafusa et al. Nature Communications
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
- (2010) Nicolas Dzamko et al. BIOCHEMICAL JOURNAL
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
- (2010) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation
- (2010) Zdenek Berger et al. BIOCHEMISTRY
- A proximity ligation assay using transiently transfected, epitope-tagged proteins: application for in situ detection of dimerized receptor tyrosine kinases
- (2010) Aaron Gajadhar et al. BIOTECHNIQUES
- MKK6 binds and regulates expression of Parkinson’s disease-related protein LRRK2
- (2010) Cindy H. Hsu et al. JOURNAL OF NEUROCHEMISTRY
- Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
- (2010) Veronique Daniëls et al. JOURNAL OF NEUROCHEMISTRY
- Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
- (2010) Christian Johannes Gloeckner et al. JOURNAL OF PROTEOME RESEARCH
- Heterodimerization of Lrrk1–Lrrk2: Implications for LRRK2-associated Parkinson disease
- (2010) Justus C. Dachsel et al. MECHANISMS OF AGEING AND DEVELOPMENT
- LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins
- (2010) C.H. Hsu et al. Neurodegenerative Diseases
- The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization
- (2010) B Titz et al. ONCOGENE
- The function of ROCO proteins in health and disease
- (2009) Patrick A. Lewis BIOLOGY OF THE CELL
- The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7,in vitro
- (2009) Christian Johannes Gloeckner et al. JOURNAL OF NEUROCHEMISTRY
- Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment
- (2009) Christian L. Klein et al. JOURNAL OF NEUROCHEMISTRY
- Abnormal Localization of Leucine-Rich Repeat Kinase 2 to the Endosomal-Lysosomal Compartment in Lewy Body Disease
- (2009) Shinji Higashi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins
- (2008) M. Michaelis et al. CLINICAL CANCER RESEARCH
- LRRK2 regulates synaptic vesicle endocytosis
- (2008) Narae Shin et al. EXPERIMENTAL CELL RESEARCH
- The Roco protein family: a functional perspective
- (2008) Ignacio Marín et al. FASEB JOURNAL
- The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation
- (2008) Elisa Greggio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ancient Origin of the Parkinson Disease Gene LRRK2
- (2008) Ignacio Marín JOURNAL OF MOLECULAR EVOLUTION
- The Chaperone Activity of Heat Shock Protein 90 Is Critical for Maintaining the Stability of Leucine-Rich Repeat Kinase 2
- (2008) L. Wang et al. JOURNAL OF NEUROSCIENCE
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
- (2008) K. Haugarvoll et al. NEUROLOGY
- The biology and pathobiology of LRRK2: Implications for Parkinson's disease
- (2008) Darren J. Moore PARKINSONISM & RELATED DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation